Jane’s practice focuses on general corporate and securities law, with an emphasis on representing emerging growth companies, venture capital funds and public companies.
Grafana Labs Completes $270 Million Primary and Secondary Transaction
August 21, 2024
Cooley advised Grafana Labs, the company behind ubiquitous, open and composable operational dashboards, on the successful completion of its approximately $270 million primary and secondary transaction.
Carmot Therapeutics Enters Definitive Merger Agreement With Roche
December 3, 2023
Cooley advised Carmot Therapeutics, a clinical-stage biotechnology company dedicated to developing life-changing therapeutics for people living with metabolic diseases including obesity and diabetes, on its definitive merger agreement in which Roche will acquire Carmot.
